Deep Health Ai India Ltd vs Parmax Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Deep Health AI India Ltd is ₹ 2.39 as of 04 May 10:20 . The P/E Ratio of Deep Health AI India Ltd is 65.7 as of March 2024 .The P/E Ratio of Parmax Pharma Ltd is 0 as of March 2024 . The Market Cap of Deep Health AI India Ltd is ₹ 18.91 crore as of March 2024 .The Market Cap of Parmax Pharma Ltd is ₹ 0 crore as of March 2024 . The revenue of Deep Health AI India Ltd for the Dec '25 is ₹ 4.21 crore as compare to the Sep '25 revenue of ₹ 3.51 crore. This represent the growth of 19.94% The revenue of Parmax Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Deep Health AI India Ltd for the Dec '25 is ₹ 3.67 crore as compare to the Sep '25 ebitda of ₹ 3.39 crore. This represent the growth of 8.26% The ebitda of Parmax Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Deep Health AI India Ltd changed from ₹ 0.29 crore to ₹ 3.04 crore over 7 quarters. This represents a CAGR of 282.94% The net profit of Parmax Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Deep Health AI India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Parmax Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Deep Health AI India Ltd

Deep Diamond India Limited was established in 1994, with the object to engaged in the manufacture and wholesale of gold set jewellery with diamonds.
The company also deals in loose diamonds, solitaires, and gold frames.
It offers Pendants, Nose pins, Rings, Bangles, Earrings, Pendant sets, Necklace sets, Bracelets, and others. From financial year 2022-23, the Company has also started business of providing consultancy service to Pharmaceutical Industry. During year 2023, Company diversified its business into pharmaceuticals business with professional management team at its Board.
Located in Mumbai, Deep Diamond India is a pharmaceutical company that focuses on developing and marketing innovative drugs and therapies to address unmet medical needs.
Their product portfolio includes prescription drugs, over-the-counter medicines, and medical devices.

About Parmax Pharma Ltd

Incorporated in November, 1994, Parmax Pharma Limited (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations.
The Company has manufacturing facilities approved by Indian regulatory bodies such as CDSCO, State FDA, and operates under GMP-compliant systems. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
The Company then discontinued their business activities for few years due to various reasons.
Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

FAQs for the comparison of Deep Health AI India Ltd and Parmax Pharma Ltd

Which company has a larger market capitalization, Deep Diamond India Ltd or Parmax Pharma Ltd?

Market cap of Deep Diamond India Ltd is 34 Cr while Market cap of Parmax Pharma Ltd is 11 Cr

What are the key factors driving the stock performance of Deep Diamond India Ltd and Parmax Pharma Ltd?

The stock performance of Deep Diamond India Ltd and Parmax Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Deep Diamond India Ltd and Parmax Pharma Ltd?

As of May 4, 2026, the Deep Diamond India Ltd stock price is INR ₹2.4. On the other hand, Parmax Pharma Ltd stock price is INR ₹30.02.

How do dividend payouts of Deep Diamond India Ltd and Parmax Pharma Ltd compare?

To compare the dividend payouts of Deep Diamond India Ltd and Parmax Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.